Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Enterprise Value (2009 - 2026)

Updated

Vertex Pharmaceuticals' Enterprise Value came in at $117.99 billion for Q2 2026, up 9.5% from $107.72 billion a year earlier and up 11.1% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Enterprise Value (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vertex Pharmaceuticals reported Enterprise Value of $97.85 billion, up 10.1% year-over-year; for FY2025, it was $108.54 billion, up 11.5% from FY2024.

  • Enterprise Value has increased in each of the last four years, with a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
  • Going back by year, Enterprise Value was $97.35 billion in FY2024 (+4.0%), $93.64 billion in FY2023 (+47.6%), $63.44 billion in FY2022 (+31.2%) and $48.36 billion in FY2021 (-11.7%).
  • The Q2 2026 figure represents the highest quarterly Enterprise Value since Q1 2025.
  • Year-over-year, Enterprise Value increased in five of the last eight quarters, with growth averaging 7.2%.
  • The fastest year-over-year change in Enterprise Value over five years came in Q3 2022 (growth of 63.3%), and the weakest in Q3 2021 (a decline of 38.9%).
  • Business Quant data shows VRTX's Enterprise Value at $106.25 billion (Q1 2026), $108.54 billion (Q4 2025) and $93.17 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.99 Bn
Mar 31, 2026 106.25 Bn
Dec 31, 2025 108.54 Bn
Sep 30, 2025 93.17 Bn
Jun 30, 2025 107.72 Bn
Mar 31, 2025 118.38 Bn
Dec 31, 2024 97.35 Bn
Sep 30, 2024 113.35 Bn
Jun 30, 2024 115.14 Bn
Mar 31, 2024 97.80 Bn
Dec 31, 2023 93.64 Bn
Sep 30, 2023 77.73 Bn
Jun 30, 2023 79.48 Bn
Mar 31, 2023 70.72 Bn
Dec 31, 2022 63.44 Bn
Sep 30, 2022 64.54 Bn
Jun 30, 2022 62.89 Bn
Mar 31, 2022 58.46 Bn
Dec 31, 2021 48.36 Bn
Sep 30, 2021 39.51 Bn
API Access

Vertex Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=VRTX&period=max&api_key=YOUR_API_KEY